Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 461

1.

Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist.

Carubbi F, Cappellini MD, Fargion S, Fracanzani AL, Nascimbeni F.

Dig Liver Dis. 2020 Feb 11. pii: S1590-8658(20)30030-X. doi: 10.1016/j.dld.2020.01.004. [Epub ahead of print] Review.

PMID:
32057684
2.

Hyperferritinemia and Diagnosis of type 1 Gaucher Disease.

Marchi G, Nascimbeni F, Motta I, Busti F, Carubbi F, Cappellini MD, Pietrangelo A, Corradini E, Piperno A, Girelli D.

Am J Hematol. 2020 Feb 7. doi: 10.1002/ajh.25752. [Epub ahead of print] No abstract available.

PMID:
32031266
3.

Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment?

Matte A, Cappellini MD, Iolascon A, Enrica F, De Franceschi L.

Expert Opin Investig Drugs. 2020 Jan;29(1):23-31. doi: 10.1080/13543784.2020.1703947. Epub 2019 Dec 25. Review.

PMID:
31847604
4.

A new approach for anemia in kidney disease.

Messa P, Cappellini MD.

Eur J Intern Med. 2020 Jan;71:1-3. doi: 10.1016/j.ejim.2019.10.035. Epub 2019 Nov 26. No abstract available.

PMID:
31784191
5.

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update.

Iolascon A, De Franceschi L, Muckenthaler M, Taher A, Rees D, de Montalembert M, Rivella S, Eleftheriou A, Cappellini MD.

Hemasphere. 2019 Jun 4;3(3):e208. doi: 10.1097/HS9.0000000000000208. eCollection 2019 Jun. Review.

6.

Treatment with ferric carboxymaltose in stable patients with severe iron deficiency anemia in the emergency department.

Motta I, Mantovan G, Consonni D, Brambilla AM, Materia M, Porzio M, Migone De Amicis M, Montano N, Cappellini MD.

Intern Emerg Med. 2019 Nov 9. doi: 10.1007/s11739-019-02223-z. [Epub ahead of print]

PMID:
31707563
7.

Iron deficiency anaemia revisited.

Cappellini MD, Musallam KM, Taher AT.

J Intern Med. 2020 Feb;287(2):153-170. doi: 10.1111/joim.13004. Epub 2019 Nov 12. Review.

PMID:
31665543
8.

Management of age-associated medical complications in patients with β-thalassemia.

Motta I, Mancarella M, Marcon A, Vicenzi M, Cappellini MD.

Expert Rev Hematol. 2020 Jan;13(1):85-94. doi: 10.1080/17474086.2020.1686354. Epub 2019 Nov 12.

PMID:
31661637
9.

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.

Gouya L, Ventura P, Balwani M, Bissell DM, Rees DC, Stölzel U, Phillips JD, Kauppinen R, Langendonk JG, Desnick RJ, Deybach JC, Bonkovsky HL, Parker C, Naik H, Badminton M, Stein PE, Minder E, Windyga J, Bruha R, Cappellini MD, Sardh E, Harper P, Sandberg S, Aarsand AK, Andersen J, Alegre F, Ivanova A, Talbi N, Chan A, Querbes W, Ko J, Penz C, Liu S, Lin T, Simon A, Anderson KE.

Hepatology. 2019 Sep 12. doi: 10.1002/hep.30936. [Epub ahead of print]

PMID:
31512765
10.

The autophagy-activating kinase ULK1 mediates clearance of free α-globin in β-thalassemia.

Lechauve C, Keith J, Khandros E, Fowler S, Mayberry K, Freiwan A, Thom CS, Delbini P, Romero EB, Zhang J, Motta I, Tillman H, Cappellini MD, Kundu M, Weiss MJ.

Sci Transl Med. 2019 Aug 21;11(506). pii: eaav4881. doi: 10.1126/scitranslmed.aav4881.

PMID:
31434755
11.

Oocyte quality in women with thalassaemia major: insights from IVF cycles.

Mensi L, Borroni R, Reschini M, Cassinerio E, Vegetti W, Baldini M, Cappellini MD, Somigliana E.

Eur J Obstet Gynecol Reprod Biol X. 2019 May 13;3:100048. doi: 10.1016/j.eurox.2019.100048. eCollection 2019 Jul.

12.

UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia.

Iurlo A, Bucelli C, Cattaneo D, Levati GV, Viani B, Tavazzi D, Consonni D, Baldini L, Cappellini MD.

Am J Hematol. 2019 Nov;94(11):E283-E285. doi: 10.1002/ajh.25596. Epub 2019 Aug 9. No abstract available.

13.

Quality of life in patients with β-thalassemia: A prospective study of transfusion-dependent and non-transfusion-dependent patients in Greece, Italy, Lebanon, and Thailand.

Cappellini MD, Kattamis A, Viprakasit V, Sutcharitchan P, Pariseau J, Laadem A, Jessent-Ciaravino V, Taher A.

Am J Hematol. 2019 Oct;94(10):E261-E264. doi: 10.1002/ajh.25584. Epub 2019 Aug 13. No abstract available.

14.

Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.

Russo G, De Franceschi L, Colombatti R, Rigano P, Perrotta S, Voi V, Palazzi G, Fidone C, Quota A, Graziadei G, Pietrangelo A, Pinto V, Ruffo GB, Sorrentino F, Venturelli D, Casale M, Ferrara F, Sainati L, Cappellini MD, Piga A, Maggio A, Forni GL.

Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0. Review.

15.

International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias.

Chen B, Whatley S, Badminton M, Aarsand AK, Anderson KE, Bissell DM, Bonkovsky HL, Cappellini MD, Floderus Y, Friesema ECH, Gouya L, Harper P, Kauppinen R, Loskove Y, Martásek P, Phillips JD, Puy H, Sandberg S, Schmitt C, To-Figueras J, Weiss Y, Yasuda M, Deybach JC, Desnick RJ.

Genet Med. 2019 Nov;21(11):2605-2613. doi: 10.1038/s41436-019-0537-7. Epub 2019 May 10.

PMID:
31073229
16.

Red blood cell distribution width as a prognostic factor of mortality in elderly patients firstly hospitalized due to heart failure.

Salvatori M, Formiga F, Moreno-Gónzalez R, Chivite D, Migone De Amicis M, Cappellini MD, Corbella X.

Kardiol Pol. 2019 Jun 25;77(6):632-638. doi: 10.33963/KP.14818. Epub 2019 Apr 29.

17.

Development of a thalassemia-related thrombosis risk scoring system.

Taher AT, Cappellini MD, Musallam KM.

Am J Hematol. 2019 Aug;94(8):E207-E209. doi: 10.1002/ajh.25502. Epub 2019 May 13. No abstract available.

PMID:
31056770
18.

Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP).

Elli L, Norsa L, Zullo A, Carroccio A, Girelli C, Oliva S, Romano C, Leandro G, Bellini M, Marmo R, Soncini M, Monica F, De Francesco V, Paulon E, Cappellini MD, Motta I, Ferretti F, Orlando S, Mansueto P, Buscarini E, Manfredi G, Agostoni C, Tomba C, Cannizzaro R.

Dig Liver Dis. 2019 Apr;51(4):471-483. doi: 10.1016/j.dld.2019.01.022. Epub 2019 Feb 11.

PMID:
30850345
19.

Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation.

Barcellini W, Zaninoni A, Gregorini AI, Soverini G, Duca L, Fattizzo B, Giannotta JA, Pedrotti P, Vercellati C, Marcello AP, Fermo E, Bianchi P, Cappellini MD.

Br J Haematol. 2019 May;185(3):523-531. doi: 10.1111/bjh.15811. Epub 2019 Mar 3.

PMID:
30828802
20.

Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia.

Marktel S, Scaramuzza S, Cicalese MP, Giglio F, Galimberti S, Lidonnici MR, Calbi V, Assanelli A, Bernardo ME, Rossi C, Calabria A, Milani R, Gattillo S, Benedicenti F, Spinozzi G, Aprile A, Bergami A, Casiraghi M, Consiglieri G, Masera N, D'Angelo E, Mirra N, Origa R, Tartaglione I, Perrotta S, Winter R, Coppola M, Viarengo G, Santoleri L, Graziadei G, Gabaldo M, Valsecchi MG, Montini E, Naldini L, Cappellini MD, Ciceri F, Aiuti A, Ferrari G.

Nat Med. 2019 Feb;25(2):234-241. doi: 10.1038/s41591-018-0301-6. Epub 2019 Jan 21.

PMID:
30664781
21.

Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.

Brancaleoni V, Moukhadder HM, Consonni D, Koussa S, Di Pierro E, Cappellini MD, Taher A.

Ann Hematol. 2019 Apr;98(4):833-840. doi: 10.1007/s00277-018-3567-3. Epub 2018 Nov 30.

PMID:
30506348
22.

Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© ).

Taher A, Viprakasit V, Cappellini MD, Sutcharitchan P, Ward R, Mahmoud D, Laadem A, Khan A, Gwaltney C, Harding G, Attie K, Zhang X, Zou J, Pariseau J, Hu XH, Kattamis A.

Am J Hematol. 2019 Feb;94(2):171-176. doi: 10.1002/ajh.25343. Epub 2018 Nov 26.

23.

Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© ).

Taher A, Cappellini MD, Viprakasit V, Sutcharitchan P, Mahmoud D, Laadem A, Khan A, Gwaltney C, Harding G, Attie K, Zhang X, Zou J, Pariseau J, Henry Hu X, Kattamis A.

Am J Hematol. 2019 Feb;94(2):177-183. doi: 10.1002/ajh.25344. Epub 2018 Nov 26.

24.

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study.

Cappellini MD, Porter J, Origa R, Forni GL, Voskaridou E, Galactéros F, Taher AT, Arlet JB, Ribeil JA, Garbowski M, Graziadei G, Brouzes C, Semeraro M, Laadem A, Miteva D, Zou J, Sung V, Zinger T, Attie KM, Hermine O.

Haematologica. 2019 Mar;104(3):477-484. doi: 10.3324/haematol.2018.198887. Epub 2018 Oct 18.

25.

How I manage medical complications of β-thalassemia in adults.

Taher AT, Cappellini MD.

Blood. 2018 Oct 25;132(17):1781-1791. doi: 10.1182/blood-2018-06-818187. Epub 2018 Sep 11. Review.

26.

Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease.

Nascimbeni F, Cassinerio E, Dalla Salda A, Motta I, Bursi S, Donatiello S, Spina V, Cappellini MD, Carubbi F.

Mol Genet Metab. 2018 Sep;125(1-2):64-72. doi: 10.1016/j.ymgme.2018.08.004. Epub 2018 Aug 11.

PMID:
30115580
27.

Circulating cell-free DNA and ineffective erythropoiesis in nontransfusion-dependent β-thalassemia.

Tavazzi D, Motta I, Graziadei G, Sampietro M, Duca L, Cappellini MD.

Am J Hematol. 2018 Nov;93(11):E365-E368. doi: 10.1002/ajh.25248. Epub 2018 Sep 9. No abstract available.

28.

Non-transferrin-bound iron and oxidative stress during allogeneic hemopoietic stem cell transplantation in patients with or without iron overload.

Duca L, Cappellini MD, Baronciani D, Pilo F, Targhetta C, Visani G, Nava I, Angelucci E.

Am J Hematol. 2018 Sep;93(9):E250-E252. doi: 10.1002/ajh.25201. Epub 2018 Aug 9. No abstract available.

29.

Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited.

Derchi G, Dessì C, Bina P, Cappellini MD, Piga A, Perrotta S, Tartaglione I, Giuditta M, Longo F, Origa R, Quarta A, Pinto V, Forni GL; Webthal®.

Intern Emerg Med. 2019 Apr;14(3):365-370. doi: 10.1007/s11739-018-1890-2. Epub 2018 Jun 12.

PMID:
29948832
30.

Clinical outcomes of Clostridium difficile infection according to strain type. A prospective study in medical wards.

Serafino S, Consonni D, Migone De Amicis M, Sisto F, Domeniconi G, Formica S, Zarantonello M, Maraschini A, Cappellini MD, Spigaglia P, Barbanti F, Castaldi S, Fabio G.

Eur J Intern Med. 2018 Aug;54:21-26. doi: 10.1016/j.ejim.2018.03.015. Epub 2018 Apr 9.

PMID:
29650357
31.

Low-dose Synachten test with measurement of salivary cortisol in adult patients with β-thalassemia major.

Ambrogio AG, Danesi L, Baldini M, Radin R, Cassinerio E, Graziadei G, Mirra N, D'Angelo E, Marcon A, Mancarella M, Orsatti A, Bonetti F, Scacchi M, Cappellini MD, Persani L, Pecori Giraldi F.

Endocrine. 2018 May;60(2):348-354. doi: 10.1007/s12020-018-1562-z. Epub 2018 Mar 23.

32.

An unusual diagnosis in a 31-year-old man with abdominal pain and hyponatremia.

Depetri F, Cugno M, Graziadei G, Di Pierro E, Granata F, Peyvandi F, Cappellini MD.

Intern Emerg Med. 2018 Dec;13(8):1233-1238. doi: 10.1007/s11739-018-1826-x. Epub 2018 Mar 17. No abstract available.

PMID:
29550908
33.

Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula.

Dell'Arti L, Barteselli G, Riva L, Carini E, Graziadei G, Benatti E, Invernizzi A, Cappellini MD, Viola F.

PLoS One. 2018 Mar 1;13(3):e0193582. doi: 10.1371/journal.pone.0193582. eCollection 2018.

34.

Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment.

Torlasco C, Cassinerio E, Roghi A, Faini A, Capecchi M, Abdel-Gadir A, Giannattasio C, Parati G, Moon JC, Cappellini MD, Pedrotti P.

PLoS One. 2018 Feb 21;13(2):e0192890. doi: 10.1371/journal.pone.0192890. eCollection 2018.

35.

Hypercoagulability and Vascular Disease.

Taher AT, Cappellini MD, Bou-Fakhredin R, Coriu D, Musallam KM.

Hematol Oncol Clin North Am. 2018 Apr;32(2):237-245. doi: 10.1016/j.hoc.2017.11.001. Epub 2017 Dec 1. Review.

PMID:
29458729
36.

Clinical Complications and Their Management.

Marcon A, Motta I, Taher AT, Cappellini MD.

Hematol Oncol Clin North Am. 2018 Apr;32(2):223-236. doi: 10.1016/j.hoc.2017.11.005. Epub 2017 Dec 28. Review.

PMID:
29458728
37.

A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?

Cappellini MD, Porter JB, Viprakasit V, Taher AT.

Blood Rev. 2018 Jul;32(4):300-311. doi: 10.1016/j.blre.2018.02.001. Epub 2018 Feb 12. Review.

38.

Microcytosis is important in screening of iron deficiency anemia.

De Franceschi L, Iolascon A, Taher A, Cappellini MD.

Eur J Intern Med. 2018 Feb;48:e39. doi: 10.1016/j.ejim.2017.08.021. Epub 2018 Feb 1. No abstract available.

PMID:
29361474
39.

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

Sleiman J, Tarhini A, Bou-Fakhredin R, Saliba AN, Cappellini MD, Taher AT.

Int J Mol Sci. 2018 Jan 8;19(1). pii: E182. doi: 10.3390/ijms19010182. Review.

40.

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.

Bou-Fakhredin R, Bazarbachi AH, Chaya B, Sleiman J, Cappellini MD, Taher AT.

Int J Mol Sci. 2017 Dec 20;18(12). pii: E2778. doi: 10.3390/ijms18122778. Review.

41.

New therapeutic targets in transfusion-dependent and -independent thalassemia.

Cappellini MD, Motta I.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):278-283. doi: 10.1182/asheducation-2017.1.278. Review.

42.

Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.

Rigano P, De Franceschi L, Sainati L, Piga A, Piel FB, Cappellini MD, Fidone C, Masera N, Palazzi G, Gianesin B, Forni GL; Italian Multicenter Study of Hydroxyurea in Sickle Cell Anemia Investigators.

Blood Cells Mol Dis. 2018 Mar;69:82-89. doi: 10.1016/j.bcmd.2017.08.017. Epub 2017 Oct 9.

43.

What is behind a relapse of thrombotic thrombocytopenic purpura?

Capecchi M, Artoni A, Cappellini MD, Graziadei G.

Intern Emerg Med. 2018 Aug;13(5):709-712. doi: 10.1007/s11739-017-1764-z. Epub 2017 Nov 2. No abstract available.

PMID:
29094300
44.

Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.

Origa R, Ponti ML, Filosa A, Galeota Lanza A, Piga A, Saracco GM, Pinto V, Picciotto A, Rigano P, Madonia S, Rosso R, D'Ascola D, Cappellini MD, D'Ambrosio R, Tartaglione I, De Franceschi L, Gianesin B, Di Marco V, Forni GL; Italy for THAlassemia and hepatitis C Advance - Società Italiana Talassemie ed Emoglobinopatie (ITHACA-SITE).

Am J Hematol. 2017 Dec;92(12):1349-1355. doi: 10.1002/ajh.24911. Epub 2017 Oct 19.

45.

Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).

Maira D, Cassinerio E, Marcon A, Mancarella M, Fraquelli M, Pedrotti P, Cappellini MD.

Ann Hematol. 2017 Nov;96(11):1931-1936. doi: 10.1007/s00277-017-3120-9. Epub 2017 Sep 5.

PMID:
28875336
46.

Thalassaemia.

Taher AT, Weatherall DJ, Cappellini MD.

Lancet. 2018 Jan 13;391(10116):155-167. doi: 10.1016/S0140-6736(17)31822-6. Epub 2017 Jul 31. Review.

PMID:
28774421
47.

Transcranial color Doppler in stroke-free adult patients with sickle cell disease.

Graziadei G, Casoni FM, Annoni F, Cortinovis I, Ridolfi P, Gandolfi I, Marcon A, Di Pierro E, Cappellini MD.

Ann Hematol. 2017 Sep;96(9):1547-1555. doi: 10.1007/s00277-017-3071-1. Epub 2017 Jul 20.

PMID:
28730452
48.

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group.

Concolino D, Amico L, Cappellini MD, Cassinerio E, Conti M, Donati MA, Falvo F, Fiumara A, Maccarone M, Manna R, Matucci A, Musumeci MB, Nicoletti A, Nisticò R, Papadia F, Parini R, Peluso D, Pensabene L, Pisani A, Pistone G, Rigoldi M, Romani I, Tenuta M, Torti G, Veroux M, Zachara E.

Mol Genet Metab Rep. 2017 Jun 22;12:85-91. doi: 10.1016/j.ymgmr.2017.06.005. eCollection 2017 Sep.

49.

Decompensated Cirrhosis and Sickle Cell Disease: Case Reports and Review of the Literature.

D'Ambrosio R, Maggioni M, Donato MF, Lampertico P, Cappellini MD, Graziadei G.

Hemoglobin. 2017 Mar;41(2):131-133. doi: 10.1080/03630269.2017.1341420. Review.

PMID:
28696845
50.

Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density.

Baldini M, Casirati G, Ulivieri FM, Cassinerio E, Khouri Chalouhi K, Poggiali E, Borin L, Burghignoli V, Cesana BM, Cappellini MD.

Blood Cells Mol Dis. 2018 Feb;68:148-152. doi: 10.1016/j.bcmd.2017.06.003. Epub 2017 Jun 16.

PMID:
28693786

Supplemental Content

Loading ...
Support Center